School of Medicine, University of Washington, Seattle, Washington, USA.
Department of Public Health, Xi'an Jiaotong-Liverpool University, Suzhou, Jiangsu, China.
Sex Transm Infect. 2018 Nov;94(7):502-507. doi: 10.1136/sextrans-2018-053549. Epub 2018 May 19.
Hepatitis B virus (HBV) and hepatitis C virus (HCV) cause substantial morbidity and mortality in low-income and middle-income countries, including China. WHO guidelines recommend men who have sex with men (MSM) receive HBV and HCV screening. The purpose of this study was to determine the proportion of MSM in China who have HBV and HCV tested and identify correlates of test uptake.
We conducted an online cross-sectional survey of young MSM in China. Respondents were asked to report previous HBV and HCV testing, sociodemographic information, sexual risk factors for hepatitis infection, other STI testing and primary care physician (PCP) status. Associations were analysed by logistic regression.
503 eligible MSM completed the survey. 41.0% (206/503) of MSM had HCV tested, and 38.2% (60/157) of MSM with no or uncertain HBV vaccination had HBV tested. In multivariate analysis, HCV testing was correlated with HBV testing (adjusted OR (aOR) 22.98, 95% CI 12.11 to 43.60), HIV testing (aOR 3.64, 95% CI 1.92 to 6.91), HIV-positive status (aOR 1.78, 95% CI 1.07 to 2.98) and having a PCP (aOR 2.40, 95% CI 1.44 to 3.98). Among MSM with no or uncertain HBV vaccination, HBV testing was correlated with HCV testing (aOR 80.85, 95% CI 20.80 to 314.33), HIV testing (aOR 5.26, 95% CI 1.81 to 15.28), HIV-positive status (aOR 3.00, 95% CI 1.22 to 7.37) and having a PCP (aOR 2.69, 95% CI 1.00 to 7.26).
Our data suggest many young MSM in China have not received hepatitis testing. HCV testing rates were lower than those recently reported among MSM in Australia and the USA. The strong correlation between HBV and HCV testing suggests bundled testing interventions may be useful for MSM in China. Men with a PCP were more likely to have received hepatitis testing, consistent with literature demonstrating the importance of primary care in expanding access to testing.
乙型肝炎病毒(HBV)和丙型肝炎病毒(HCV)在包括中国在内的低收入和中等收入国家造成了大量的发病率和死亡率。世界卫生组织(WHO)指南建议男男性行为者(MSM)接受 HBV 和 HCV 筛查。本研究旨在确定中国 MSM 中接受 HBV 和 HCV 检测的比例,并确定检测采用的相关因素。
我们对中国的年轻 MSM 进行了在线横断面调查。被调查者被要求报告以前的 HBV 和 HCV 检测情况、社会人口学信息、肝炎感染的性风险因素、其他性传播感染(STI)检测和初级保健医生(PCP)状况。采用逻辑回归分析相关性。
503 名符合条件的 MSM 完成了调查。41.0%(206/503)的 MSM 接受了 HCV 检测,38.2%(60/157)未接种或不确定 HBV 疫苗的 MSM 接受了 HBV 检测。多变量分析显示,HCV 检测与 HBV 检测相关(调整后的比值比[aOR]22.98,95%置信区间[CI]12.11 至 43.60)、HIV 检测(aOR 3.64,95%CI 1.92 至 6.91)、HIV 阳性状态(aOR 1.78,95%CI 1.07 至 2.98)和有 PCP(aOR 2.40,95%CI 1.44 至 3.98)。在未接种或不确定 HBV 疫苗的 MSM 中,HBV 检测与 HCV 检测相关(aOR 80.85,95%CI 20.80 至 314.33)、HIV 检测(aOR 5.26,95%CI 1.81 至 15.28)、HIV 阳性状态(aOR 3.00,95%CI 1.22 至 7.37)和有 PCP(aOR 2.69,95%CI 1.00 至 7.26)。
我们的数据表明,中国许多年轻的 MSM 尚未接受肝炎检测。HCV 检测率低于澳大利亚和美国最近报告的 MSM 检测率。HBV 和 HCV 检测之间的强相关性表明,捆绑检测干预措施可能对中国的 MSM 有用。有 PCP 的男性更有可能接受肝炎检测,这与文献表明初级保健在扩大检测机会方面的重要性一致。